Evaluating the effects of sulthiame on EEG in children with epilepsy
Official title: Treatment of Epilepsy Syndromes of Childhood With Sleep Activation Using Sulthiame: an Exploratory Study of the Short Term Effect on EEG
Run by University Hospital, Angers · NCT05885646 · Data updated 2026-11-12
This study tests if the medication sulthiame can change sleep brain activity in children with epilepsy who haven't had success with other treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 6 Years to 15 Years |
| Sex | All |
| Enrollment | 15 (estimated) |
| Sponsor | University Hospital, Angers Government |
| Locations | 3 sites (Angers and 2 other locations) |
| Status | Recruiting |
| Started | October 17, 2023 |
| Main results expected | December 1, 2025 |
| Study ends | December 1, 2025 |
| Registry record updated | June 15, 2025 |
| Trial ID | NCT05885646 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children diagnosed with epilepsy syndromes that exhibit sleep activation and have not responded to at least two anti-epileptic medications.
✕Probably not a fit
Patients who have previously participated in a trial with sulthiame or are currently using corticosteroids may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the impact of sulthiame on sleep EEG in children diagnosed with epilepsy syndromes characterized by sleep activation. Participants will undergo sleep EEG recordings at baseline and after 2 and 4 weeks of treatment to assess any changes in interictal epileptiform activity. The study aims to determine if the effects of sulthiame can be identified after two weeks of treatment, providing insights into its efficacy in managing childhood epilepsy. The study includes children who have previously failed at least two anti-epileptic drugs.
Why it matters
Potential benefit: If successful, this study could provide valuable information on the effectiveness of sulthiame in reducing epileptiform activity in children with epilepsy.
How similar studies have gone: While the specific effects of sulthiame on EEG in childhood epilepsy have not been extensively studied, similar approaches in evaluating anti-epileptic drugs have shown promise in other contexts.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of epilepsy syndromes of childhood with sleep activation * Failure of at least two anti-epileptic drugs (AED) * Sleep EEG performed in the last 7 days before inclusion and showing interictal epileptiform discharges (baseline EEG) Exclusion Criteria: * Previous trial with sulthiame * More than 2 AED at inclusion * Use of corticosteroids at inclusion * Change in the anti-epileptic treatment in the 7 days before baseline EEG
Where it's running
-
Angers University Hospital, Pediatric department
Angers, France Recruiting -
Strasbourg University Hospital, Pediatric department
Strasbourg, France Not yet recruiting -
Toulouse University Hospital, Pediatric Neurology Department
Toulouse, France Not yet recruiting
Study contacts
- Principal investigator: Patrick Van Bogaert, Professor — University Hospital, Angers
- Study coordinator: Patrick Van Bogaert, Professor
- Email: Patrick.VanBogaert@chu-angers.fr
- Phone: 02.41.35.48.46
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sleep and Music for Kids with Epilepsy
This trial tests if a music-based program can improve sleep and health for children with epilepsy and their parents.
-
Registry and natural history of epilepsy-dyskinesia syndromes
This registry will collect health data and biological samples from people of all ages who have a genetic diagnosis of epilepsy-dyskinesia syndromes to see how their genes relate to their movement and seizure symptoms over time.
-
Cognitive Behavioral Play Therapy for Children with Epilepsy
This study is testing if Cognitive Behavioral Play Therapy can help improve the quality of life for children aged 6 to 10 with epilepsy compared to regular free play.
-
Improving executive functioning in teens with epilepsy through a web-based intervention
This study is testing a new online program to see if it can help teenagers with epilepsy improve their thinking skills and overall quality of life.
-
Registry for pediatric deep brain stimulation outcomes
This study is creating a database to collect information on how deep brain stimulation helps children with movement disorders like dystonia and Tourette syndrome, to see how safe and effective the treatment is.
-
Understanding epilepsy-dyskinesia syndromes in children
This study is trying to learn more about epilepsy-dyskinesia syndromes in children by gathering information from different countries to see how these movement and seizure disorders are related.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.